Channelopathies are disorders caused by abnormal ion channel function in differentiated excitable tissues. We discovered a unique neurodevelopmental channelopathy resulting from pathogenic variants in SCN3A, a gene encoding the voltage-gated sodium channel Na V 1.3. Pathogenic Na V 1.3 channels showed altered biophysical properties including increased persistent current. Remarkably, affected individuals showed disrupted folding (polymicrogyria) of the perisylvian cortex of the brain but did not typically exhibit epilepsy; they presented with prominent speech and oral motor dysfunction, implicating SCN3A in prenatal development of human cortical language areas. The development of this disorder parallels SCN3A expression, which we observed to be highest early in fetal cortical development in progenitor cells of the outer subventricular zone and cortical plate neurons and decreased postnatally, when SCN1A (Na V 1.1) expression increased. Disrupted cerebral cortical folding and neuronal migration were recapitulated in ferrets expressing the mutant channel, underscoring the unexpected role of SCN3A in progenitor cells and migrating neurons.
In Brief
Smith et al. define a role for sodium channel SCN3A (Na V 1.3) in the developing human cerebral cortex, as well as a cortical malformation that can result from Na V 1.3 dysfunction.
SUMMARY
Channelopathies are disorders caused by abnormal ion channel function in differentiated excitable tissues. We discovered a unique neurodevelopmental channelopathy resulting from pathogenic variants in SCN3A, a gene encoding the voltage-gated sodium channel Na V 1.3. Pathogenic Na V 1.3 channels showed altered biophysical properties including increased persistent current. Remarkably, affected individuals showed disrupted folding (polymicrogyria) of the perisylvian cortex of the brain but did not typically exhibit epilepsy; they presented with prominent speech and oral motor dysfunction, implicating SCN3A in prenatal development of human cortical language areas. The development of this disorder parallels SCN3A expression, which we observed to be highest early in fetal cortical development in progenitor cells of the outer subventricular zone and cortical plate neurons and decreased postnatally, when SCN1A (Na V 1.1) expression increased. Disrupted cerebral cortical folding and neuronal migration were recapitulated in ferrets expressing the mutant channel, underscoring the unexpected role of SCN3A in progenitor cells and migrating neurons.
INTRODUCTION
Human CNS channelopathies cause a range of brain disorders (Spillane et al., 2016) . However, we lack a clear understanding of ion channel functions at early stages of cerebral cortical development, particularly in progenitor cells and migrating neurons (Spillane et al., 2016) . Here we describe a disease of abnormal brain development, polymicrogyria (PMG), associated with pathogenic variants in SCN3A, which encodes brain-enriched voltage-gated sodium channel (VGSC) Na V 1.3. PMG is characterized by multiple abnormally small gyri in the cerebral cortex (Kuzniecky et al., 1993) . PMG in language areas can affect speech (Stutterd and Leventer, 2014) ; its location and extent correlate with the severity of the resulting developmental language disorder (Guerreiro et al., 2002; Jansen et al., 2005) . Although case reports suggest that SCN3A variants cause early infantile epilepsy, sometimes resolving in childhood (Holland et al., 2008; Lamar et al., 2017; Vanoye et al., 2014; Zaman et al., 2018) , the pathogenic SCN3A alleles we discovered manifest as a fixed perisylvian anatomical defect with prominent orofacial weakness and/or speech delay, yet epilepsy was uncommon. Our findings reveal prenatal roles for SCN3A in cortical organization and neuronal migration, especially in speech and language areas, mirroring the enriched fetal expression of SCN3A. Prenatal cortical progenitor cells and neurons do not show detectable action potentials, supporting an unexpected role for sodium channel (SCN3A) in their proliferation and migration in the developing brain. (C) Family A pedigree with a dominantly inherited point mutation causing amino acid change Phe1759Tyr in SCN3A. Family B pedigree with a dominantly inherited point mutation causing amino acid change Ile1344Leu in SCN3A. Single affected individual in Family C with a de novo point mutation causing amino acid change Leu850Pro in SCN3A. Single affected individuals in Families D and E with a de novo point mutation causing amino acid change Ile875Thr in SCN3A. Single affected individual in Family F with a point mutation causing amino acid change Arg621His in SCN3A; paternal sample unavailable (NA). Square, male; circle, female; black quadrant shading, affected individual (see phenotype legend). See also Figure S1 and Table S1 .
RESULTS AND DISCUSSION
Individuals with Pathogenic SCN3A Variants Display Aberrant Cerebral Cortical Development and Speech Deficits Magnetic resonance imaging (MRI) and neurological evaluations of six unrelated families with oral motor and/or speech deficits demonstrate bilateral perisylvian PMG (Families A and B; Figure 1A and 1B; Table S1), unilateral perisylvian PMG with abnormal sulcation (Families C and F), and bilateral frontoparietal PMG with microcephaly (Families D and E; Figure 1B ). Families A and B are multigenerational with prominent dysarthric speech, and variable oral motor deficits and ID, clinically described previously (Guerreiro et al., 2000) , compatible with autosomal dominant inheritance with incomplete penetrance ( Figure 1C ). Linkage and haplotype mapping, exome sequencing, and Sanger sequencing in Family A detected only one rare, predicted deleterious variant that segregated perfectly with the condition: it is heterozygous in affected individuals and obligate carriers and absent in unaffected individuals . The variant occurs in SCN3A, which encodes Na V 1.3 (NM_006922.3), a VGSC alpha subunit (Na V ). This channel's pore-forming structure contains four homologous domains (DI-DIV), each consisting of six membrane-spanning segments (S1-S6; Figure 2A ). The SCN3A variant in Family A, c.5276T>A, p.Phe1759Tyr (F1759Y) affects a phenylalanine in the S6 segment of the fourth transmembrane domain (DIV-S6; Figures 2A and S1A) , an important pore-facing subunit regulating voltage-dependent inactivation (McPhee et al., 1995; Savio-Galimberti et al., 2012) . A screen of 258 individuals with PMG and variable oral motor or speech deficits for SCN3A variants revealed five additional families. In Family B, the variant at c.4030A>C, p.Ile1344Leu (I1344L) affects an isoleucine in the S5 segment of the third domain (DIII-S5; Figures 1C, 2A , and S1E) and was inherited by two affected siblings from their mother who had a normal MRI, suggesting that she is a non-manifesting carrier, a feature of channelopathies (Cooper et al., 2013) . The siblings' maternal uncle, now deceased, reportedly never developed speech and had seizures but did not have brain imaging. The de novo SCN3A variant in Family C, c.2549T>C, p.Leu850Pro (L850P), present in one affected child and absent from both parents, affects a leucine in the S4 voltage-sensing segment of the second domain (DII-S4; Figures 1C, 2A , and S1F). Unrelated Families D and E each have one affected child with the same de novo variant absent from their parents, SCN3A c.2624T>C, p.Ile875Thr (I875T), which is in the intracellular loop connecting the S4-S5 subunits in DII, close to the Na V voltage sensor (Savio-Galimberti et al., 2012) (Figures 1C,  2A , and S1H). The SCN3A variant in Family F, 1862G>A, p.Arg621His (R621H), present in one affected child and absent in maternal DNA, affects an arginine in the S6-S1 cytoplasmic linker between DI and DII ( Figures 1C and S1G) . Lelieveld et al., 2016) , and two individuals with PMG and severe epilepsy (one the same as reported herein) (Zaman et al., 2018) , suggesting that I875T is a recurrent, severely damaging allele. In silico pathogenicity predictions using SIFT, MutationTaster, and PolyPhen2 suggested that R621H, L850P, I875T, I1344L, and F1759Y are all damaging and likely disease causing (STAR Methods). The mutations suggest a range of severity, from inheritance of variably penetrant perisylvian PMG and ID without epilepsy (F1759Y, I1344L) to the severely damaging recurrent I875T allele, which is de novo in the 5 families identified to date with widespread PMG, microcephaly, and severe seizures.
Pathogenic SCN3A (Na V 1.3) Variants Alter Channel Physiology Sodium current recordings from HEK293T cells that expressed mutated SCN3A harboring the F1759Y or I875T alleles displayed abnormal channel properties. Using whole-cell patch recordings, we evoked transient sodium currents over a range of voltages and measured the conductance-voltage curve in transfected cells ( Figure 2B ). Both mutant channels exhibited abnormal peak conductance (I peak ) and half-maximal voltage of activation (V 1/2 ; Figure 2C ). Compared to wild-type (WT), the F1759Y mutation produced a depolarizing shift (+7.8 ± 1.6 mV; t test, p < 0.01, n = 28), while the I875T mutation produced a hyperpolarizing shift (À5.4 ± 1.7 mV; t test, p < 0.01, n = 17; Figure 2C; see Table S2 for complete sodium current values). Na V channel availability calculated by measuring steady-state (fast) inactivation with a stepwise conditioning protocol (100 ms prepulse from À100 to 0 mV; Figure 2D ) showed a trend toward depolarizing shifts in half-maximal voltage of inactivation (F1759Y, 5.2 ± 1.1 mV, t test, p = 0.24, n = 28; and I875T, 5.5 ± 0.6 mV; t test, p = 0.27 n = 17; Figure 2D ).
Whereas SCN3A channels are already distinct from SCN1A channels by their larger, non-inactivating persistent current (I-Na P ) (Lampert et al., 2006; Sun et al., 2007) , F1759Y and I875T increased this difference further. The I-Na P measured at depolarized potentials for I875T (+10 to +50 mV; t test, n = 17, p < 0.05), and at all potentials tested for F1759Y (À10 to +50 mV; t test, n = 28, p < 0.01), was greater than WT Na V 1.3 controls ( Figure 2E ; Table S2 ).
Because I-Na P depolarizes cells (Stafstrom, 2007) and mutated SCN3A can enhance excitability (Estacion et al., 2010) , we next evaluated total charge (current density) conducted by channels during a voltage step depolarization (Figure 2F) . The F1759Y pathogenic variant conducted more sodium current through depolarizing potentials (À10 mV to +25 mV; t test, n = 28, p < 0.05), while the I875T pathogenic variant conducted less sodium current than controls (t test, n = 17, p < 0.01; Figure 2F ; Table S2 ). Because I-Na P is a characteristic of SCN3A channels and is similarly increased by both variants, it might underlie PMG associated with these variants.
Patch clamping human primary fetal cortical neurons from early-middle gestation showed small reproducible sodium currents (110 pA ± 45 pA, n = 12; Figure 2H ), but no regenerative action potentials under the tested conditions (Figure 2I) , consistent with prior reports (Moore et al., 2009 ). The absence of action potentials prenatally suggests that during human fetal development, SCN3A sodium currents may have functions beyond the classical role of action potential electrogenesis.
SCN3A Expression Is Developmentally Regulated in Human Brain
Unlike SCN1A, SCN3A is robustly expressed across human cortical regions during fetal periods but downregulated after birth (Figures 3A and S3C) . RNA in situ analyses of fetal (20 weeks gestation) human brain revealed the highest SCN3A expression in the cortical plate (CP), which contains immature neurons, with significant expression in the outer subventricular zone (oSVZ) and intermediate zone (IZ), but low expression in the ventricular zone (VZ; Figures 3C, 3E , and S3B). Consistent with this pattern, single-cell RNA sequencing (scRNA-seq) data at 16-18 weeks gestation (Pollen et al., 2015) showed SCN3A enrichment in intermediate progenitors and neurons (Figures 3B and S3A) , and in situ analysis showed expression in outer radial glia (oRG; Figures S3B) as well, a progenitor cell type present in developing gyrencephalic brains (non-human primates and humans) but rare or absent in mice (Florio and Huttner, 2014) . oRG cells, but not ventricular RG cells, display small sodium currents (Hansen et al., 2010) , suggesting that SCN3A underlies sodium conductance in these cortical progenitors, which are key to gyrification. Adult human cortex (38 years old) showed very low SCN3A expression across all cortical layers ( Figures 3D, 3F , and S3C).
SCN3A expression differs sharply from that of other VGSCs, including SCN1A, which was lower during gestation and upregulated postnatally (Figures 3A and S3C) . Low SCN1A expression during gestation was confirmed across all fetal cortical cell types by scRNA-seq (two-part Wilcoxon test, p < 0.005; Figure 3B ). Notably, postnatal upregulation of SCN1A correlates with the age of onset of epilepsy associated with SCN1A variants (Spillane et al., 2016) . Clinical reports have associated other SCN3A variants with infantile epilepsy that resolves with age (Vanoye et al., 2014) , perhaps because fetal SCN3A expression later decreases. Mice also display post-natal Scn3a downregulation (Beckh et al., 1989; Gordon et al., 1987) , and mice with lossof-function (LOF) Scn3a mutations do not display spontaneous seizures (Lamar et al., 2017) . Thus, different expression patterns between SCN1A and SCN3A may relate to the ages of onset and severity of VGSC channelopathies, possibly explaining the limited adult epilepsy observed in individuals with SCN3A pathogenic variants in this study (Families A, B, C, and E), and the absence of brain malformations seen with SCN1A mutations (Spillane et al., 2016) .
Overexpression of SCN3A in Human Cortical Neurons Stimulates Neurite Branching but Is Impaired by I875T and F1759Y Mutants Expression of SCN3A in cultured human fetal neurons produced a modest increase in neurite branching without an overall increase in neurite length, and this branching effect was attenuated by both I875T and F1759Y mutants ( Figure S2 ). Fetal neurons overexpressing the I875T mutant displayed modestly shorter neurites overall, similar to neuropathy-associated Na V 1.7 mutations that disrupts neurites (Estacion et al., 2015) , whereas SCN3A-F1759Y showed no differences compared to controls ( Figure S2C ). Overexpression of the b-Na V subunit, which affects persistent current (Aman et al., 2009) , increased neurite length ( Figure S2C ), consistent with previous reports in rodent cortical neurons (Brackenbury et al., 2008) . These results further support the possibility that SCN3A regulates neuronal development through action potential-independent mechanisms and that the disease-associated mutations impact these processes.
Altered SCN3A Expression Disrupts Ferret Cerebral Cortical Development SCN3A-F1759Y mutation disrupted cortical gyral formation in vivo in the developing ferret cerebral cortex (Figure 4 ). Unlike rodents, ferret brains possess a stereotyped pattern of gyri and sulci, a human-like molecular diversity of progenitor cells, and a developmental timeline that permits transient gene overexpression in embryos via in utero electroporation (IUE) (Johnson et al., 2015; Kawasaki et al., 2012) . Following IUE delivery of F1759Y or WT SCN3A at embryonic day 33 (E33), we analyzed ferret brains at: (1) birth (postnatal day 0 [P0]), coincident with mid-corticogenesis (cortical layers are still forming and cortex largely smooth), and (2) P33, when gyri and sulci are more fully formed. At P0, F1759Y overexpression severely disrupted neuronal migration: Tuj1-positive neurons were displaced near the VZ and SVZ instead of arriving at their age-appropriate cortical laminae ( Figure 4C ). At P33 (Figure 4E ), F1759Y-transfected embryos developed atypical gyrification patterns, including the formation of additional sulci and gyri (5 of 5 ferrets (legend continued on next page) examined; Figures 4E and S4C) . At both time points (P0 and P33), the overexpression of SCN3A-WT had modest effects: neuronal migration was slightly altered at P0 (Figure 4B ), perhaps resulting from enhanced sodium entry, and the gyral phenotype was modestly affected at P33 (2 of 6 ferrets examined; Figures  4H and S4C) . Similar injections of a control vector did not alter the gyrification pattern (0 of 5 ferrets examined; Figures 4J  and S4C) .
Finally, reconstruction of MRI images of adult ferret cortices revealed formation of cortical gray matter heterotopia in SCN3A-F1759Y-expressing brains ( Figure 4F ), but not in SCN3A-WT or empty vector controls ( Figures 4I and 4K) . Heterotopia consisted of displaced F1759Y mCherry-positive cells ( Figure 4G ), intermixed with mCherry-negative and SATB2-positive cells, an upper layer cortical maker ( Figure S4E ), suggesting that some of the migratory defect involved WT cells disrupted non-cell-autonomously, perhaps by loss or damage to radial glia that do not normally express SCN3A. Evaluation of SATB2-positive cells at P15 also confirmed robust displacement of these cells in electroporated regions ( Figure S4D ). MRI analyses of SCN3A-WT and empty vector-expressing controls did not show displaced cells or heterotopia ( Figures 4I and 4K) . Together, these findings further support the model that SCN3A gene dosage, in addition to acquired pathological mutations, alters early cerebral cortical development, with sodium channel dysregulation leading to both cell-autonomous effects in neurons and potential effects on other cell types as well.
Prenatal SCN3A may not always involve classic action potential upstroke generation. Human oRG and astrocytes show functional sodium channels, with small and prolonged conductances, but no action potentials (Black et al., 1995; Hansen et al., 2010; Sontheimer and Waxman, 1993 (Black and Waxman, 2013) . Fetal SCN3A mutations may activate different mechanisms than mutations in other VGSCs, like SCN1A, that are expressed postnatally, when both GOF and LOF are likely to modify excitability, altering circuit function (Blanchard et al., 2015; Escayg and Goldin, 2010) , and SCN2A, where LOF (but not GOF) is reported in individuals with autism spectrum disorders without epilepsy (Ben-Shalom et al., 2017). As channels that affect membrane potential are important for cortical development (Ackman and Crair, 2014; LoTurco et al., 1995; Rash et al., 2016) , and modifications to membrane potential in progenitor cells can disrupt cortical lamination in mice (Hurni et al., 2017) , regulation of ion flux may represent a conserved mechanism governing development of several cell types.
To date, genetic evidence connecting cortical malformations with oral motor and developmental language disorders is limited. Guerreiro et al. (2002) and Jansen et al. (2005) demonstrated the presence of a developmental language delay in individuals with bilateral perisylvian PMG, and the high prevalence of PMG in persons with developmental language delay. Both studies correlated the location and extent of the cortical malformation with the type and severity of developmental language delay. The perisylvian region contains key language areas that can be affected by PMG (Stutterd and Leventer, 2014) . Notably, infantile epilepsy cases with SCN3A variants not showing PMG may display variable abnormalities in oral motor and speech development (Lamar et al., 2017; Vanoye et al., 2014) . SCN3A deficits also overlap with features of syndromes caused by mutations in the N-methyl-D-aspartate receptor subunit GRIN2A and the transcription factor FOXP2 (Morgan et al., 1993; Turner et al., 2015) as well as the inherited ''Worster-Drought'' syndrome (Clark et al., 2000) , which resembles several of our SCN3A families. Understanding the early function of these genes will illuminate development of the Sylvian fissure and its adjacent perisylvian language and oral motor areas.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: pathology, with a maximum post-mortem interval of 4 h. Cases with known anomalies were excluded. Male and female brain tissue was collected from 17-20 gestation weeks. Tissue was transported in HBSS medium on ice to the laboratory for research processing.
Phenotypic assessment
All affected individuals and clinical data were examined by neurologists and radiologists, and polymicrogyria was diagnosed using criteria described previously . Detailed clinical information on affected individuals in Family A was collected over a 20-year period, summarized in Table S1 . The affected individuals of Families B -F were evaluated by neurologists over many years and detailed clinical and radiographic evaluations are described in supplemental results text.
Clinical description of families
Family A, a multigenerational Finnish family, is the largest family with bilateral perisylvian polymicrogyria (PMG) reported to date (Guerreiro et al., 2000) , having four pairs of affected siblings with variable penetrance and expression of PMG and oral motor dysfunction (dysarthric speech and deficient tongue movement) (Figures 1B and 1C ; Table S1 ). With the exception of a single rolandic seizure in one individual (A12), neurological evaluation of the affected individuals performed throughout life confirmed the absence of epilepsy in Family A. Two affected individuals (A11 and A12) showed slightly subnormal language comprehension and intellectual ability, and these features ranged from borderline normal to subnormal in others ( Figure 1C ; Table S1 ). Family B is a multigenerational French Canadian family with bilateral perisylvian PMG and oral motor dyspraxia ( Figures 1B and  1C) . As previously described, the two affected siblings (B02 and B03) had delayed speech development and a history of choking in infancy, and have dysarthria, drooling and significant restriction of tongue movements. Additionally, they were both noted to have difficulty whistling and blowing, abnormal brisk jaw jerk, increased reflexes, absent gag reflex and automatic involuntary dissociation of facial movements (Guerreiro et al., 2000) . Upon reevaluation at 43 years of age, B03 had macrocephaly with a head circumference of 57 cm (99 th percentile, 2.4 standard deviations), her height was 163 cm (48 th percentile) and her weight was 126 pounds (49 th percentile). She reported a history of having difficulty manipulating objects in childhood, and was observed to have normal muscle tone and gross motor movements, but had a mild tremor at the end of intentional movements and mild difficulty with rapid alternating movements. Prior clinical testing for B03 included a normal karyotype (46, XX) and normal IQ. B02 was evaluated on the same occasion, was 50 years of age, and presented with a very similar clinical picture as his sister, B03. B01, the daughter of B02 and previously described to have mild dysarthria and a normal brain MRI (Guerreiro et al., 2000) , was reported at 16 years of age to have intellectual disability but no speech disorder. A sister of B02 and B03 died at 16 months of age of unknown cause, and a maternal uncle never developed speech, had epilepsy and died in adulthood. Brain imaging was not available for either the deceased sister or uncle. B04, sister of B02 and B03, was unaffected. B05, the mother of B02 and B03, was unaffected and had a normal brain MRI (Guerreiro et al., 2000) and normal fluorescence in situ hybridization study of the DiGeorge syndrome region [ish 22q11.2 (TUPLE1x2)]. Family C is of Dutch descent and has a single male affected with unilateral perisylvian PMG and contralateral abnormal perisylvian sulcation with developmental motor and speech delay ( Figures 1B and 1C) . The proband has two healthy older sisters and healthy parents. He was born by induced delivery at 41 weeks gestation, following an uncomplicated pregnancy, and had a birth weight of 3.5 kg (46 th percentile). In infancy, he was unable to breastfeed and learning to chew was slow and required therapy. He presented at 1 year of age with delay of motor development and hypotonia. A brain MRI was obtained at 2 years of age, noting right-sided perisylvian PMG, involving the posterior-frontal, anterior-parietal and postero-superior temporal lobes. The posterior body and isthmus of the corpus callosum was thin, the right cerebral ventricle was mildly enlarged and white matter volume was slightly diminished in the right hemisphere. At 3 years of age, his height is 93 cm (À1.5 standard deviations) and head circumference is 52.0 cm (0.8 standard deviations). He is noted to have a prominent forehead and downward-slanting eyelids. Neurologic examination revealed axial hypotonia and very mild left pyramidal signs but no differences in strength. Vision and hearing are normal; he sleeps well and has not had any seizures. At 3 years, he is able to stably walk and tries to jump and run, has good social skills but weak executive functions. Speech is delayed, as he uses two to three word sentences only, but oral motor abilities, including articulation, swallowing and chewing, are normal. He has a normal gag reflex and no mouth breathing. Family D is of mixed European descent (Poland, Germany and Ireland) and has a single male affected with frontoparietal PMG, seizures, microcephaly, and neurodevelopmental delay ( Figures 1B and 1C) . The proband was born at 42 weeks gestation following an uncomplicated pregnancy and presented with seizures at 2 weeks of age. At 2 months of age, he had a normal head circumference and length (40 th and 80 th percentiles respectively by report), a small penis (< 10 th percentile reportedly), was non-dysmorphic, exhibited hypotonia, had feeding difficulties and apneic episodes, as well as developmental delay (not smiling or rolling). Brain MRI at 2 months of age revealed extensive coarse PMG in the frontal and parietal lobes with subcortical calcifications and abnormal frontal white matter. A thin but fully formed corpus callosum was noted and the white matter was markedly diminished, especially frontally. Upon evaluation at 1 year, he had a mixed seizure disorder with complex and simple partial seizures described as occurring 1 per day initially, worsening when he was ill, and better controlled more recently. There was significant generalized hypotonia with spasticity and upper extremity hypertonia, and he did not have complete head control. He had oral motor discoordination (unable to bottle feed but able to breastfeed), recurrent otitis media and genu valgum that did not require intervention. Developmentally, he was rolling over at 1 year but did not fully grab, hold or transfer toys from his left to right hand; he said ''ma'' and responded to his name but did not fix or follow consistently. At that time he received physical, occupational and vision therapies. Head circumference at 10 years 10 months was 49 cm (3.89 standard deviations below the mean). Ophthalmologic evaluation noted strabismus and significant cortical visual impairment with normal retina and optic nerves. At 11 years 8 months of age he has remained non-verbal, with dysphagia and mixed seizure disorder, hypotonia and severe global delay. Family E is a non-consanguineous family from the United Arab Emirates and has a single female affected with bilateral frontoparietal PMG, microcephaly and severe global developmental delay ( Figures 1B and 1C) . The proband was born at full term following an unremarkable pregnancy and delivery, and her birth weight was 3 kg (21 st percentile; À0.8 standard deviations). Hypotonia and developmental delay prompted a brain MRI at 5 months of age, which revealed bilateral PMG sparing the posterior temporal and occipital lobes; the cerebral ventricles were mildly enlarged and white matter volume slightly reduced. At 10 months of age, she had microcephaly; her head circumference was 40.7 cm (À3.2 standard deviations). At that time she was able to roll over but not sit or crawl, she had a palmar grasp only and had stereotyped movements. Neurologic evaluation revealed right esotropia, no response to visual or auditory stimuli, generalized hypotonia with head lag and normal deep tendon reflexes. At 13 months, she had not made further motor developmental progress but responded well to visual and auditory stimuli, and was social. She did not have seizures, though an EEG was reported to have shown bilateral synchronous epileptiform discharges but no medication was prescribed. Karyotype and serum lactic acid and ammonia levels were reported as normal. Another brain MRI was performed at 9 years of age that reported a thickened cortex bilaterally, shallow Sylvian fissures, slightly prominent cerebral ventricles, sparse white matter of normal signal intensity and minimally increased extra-axial cerebral spinal fluid. Follow-up evaluation at 13 years of age revealed spastic quadriplegia and global developmental delay. She was wheelchair bound, could roll over but not sit up or stand. She was nonverbal, had excessive drooling and feeding difficulties, taking soft and pureed foods orally with slow swallowing. Decreased range of motion, flexion deformity of the left wrist, equinus deformity of the left foot, and significant scoliosis with right curvature were noted. She was observed to be very attentive and smiling, and to both fix and follow appropriately. She was reported to menstruate, have urinary incontinence and have sleep disturbances. Family F is of French Canadian, Russian and Irish descent and has a single female affected with unilateral right-sided PMG and seizures ( Figures 1B and 1C) . The proband has three siblings and a father who are healthy, and her mother has a history of thyroid adenoma and left frontal meningioma. She was born at term, had a birth weight of 4.9 kg (> 99 th percentile, 3.2 standard deviations), and had an uncomplicated neonatal course. Seizures were first noted at 2 years of age and she had a history of motor developmental delay but normal speech and oral motor development. Her ability to reason and to comprehend others' language was reportedly reduced. Brain MRI at 21 years of age revealed right hemispheric PMG with the right hemisphere being smaller than the left, fully formed and thick corpus callosum, small right basal ganglia and thalamus, significant enlargement of the right lateral ventricle and severe diminution of the right hemispheric white matter. On evaluation at 28 years of age, she had macrocephaly with a head circumference of 60.5 cm (5.1 standard deviations), her height was 168 cm (77 th percentile, 0.74 standard deviations), and her weight was 188 lbs (95 th percentile, 1.7 standard deviations). Notably, her mother was also macrocephalic with a head circumference of 61 cm (6 standard deviations). Treated with Tegretol, a seizure frequency of once or twice a year was reported. She had good vision with normal visual field and extraocular movements.
METHODS DETAILS
Human genetics Leukocyte-derived DNA was utilized for studies of all families. Genome-wide genotyping was performed on individuals 1-12 in Family A using the Illumina Infinium HumanHap550-Duo BeadChip. These data were used to perform linkage and haplotype analysis. Genotypes were called using GenomeStudio Software (Illumina). Low performing SNPs (those not called in all individuals in this study or not called in > 5% of individuals run on the same chips), low variance SNPs (those with minor allele frequencies (MAF) of 0 in all individuals in this study; or that have an MAF < 10% or that deviate from HWE with P value < 0.00000001 among unrelated individuals run on the same chips), and SNPs with Mendelian and non-Mendelian errors (calculated with Merlin) were removed from the analysis using PLINK. PLINK was used to thin SNPs to reduce linkage disequilibrium. Linkage analysis was performed to generate a LOD score from the remaining SNPs using Merlin under a dominant mode of inheritance assuming a disease allele prevalence of 0.0001 and a penetrance of 0.6. Haplotype analysis was performed on the SNPs around the maximum LOD score using Merlin. Whole exome sequencing (WES) was performed at the Broad Institute using Agilent Sure-Select Human All Exon v2.0 capture array and sequenced on Illumina HiSeq2000 sequencers.
Identification and segregation of alleles
Linkage and haplotype analysis in Family A identified a candidate locus at Chromosome 2 (Figures S1B and S1C) with the highest LOD score of 2.48 at rs10930488-rs1489635; chr2: 164,028,745-172,490,226 (hg19) . Targeted sequencing was performed and the mutation identified in Family A is Chr2(GRCh37):g.165947387A>T, NM_006922.3:c.5276T>A, p.Phe1759Tyr ( Figure S1A ). Algorithms suggest that the mutation is of a highly conserved nucleotide (phyloP: 5.29 [-14.1;6.4] ), and predict the amino acid change to be deleterious [SIFT: deleterious (score: 0, median: 4.32), MutationTaster: disease-causing (p value: 1), PolyPhen-2: probably damaging (score: 1.0)]. The mutation identified in Family B is Chr2(GRCh37):g.165953971T>G, NM_006922.3:c.4030A>C, p.Ile1344Leu. Algorithms suggest that the mutation is of a highly conserved nucleotide (phyloP: 5.21 [-14.1;6.4] ), and predict the amino acid change to be deleterious [SIFT: deleterious (score: 0, median: 4.32), MutationTaster: disease-causing (p value: 1), Primary neuronal cultures and neurite analysis Neuronal cultures were prepared according to established protocols with modifications. Briefly, the perisylvian cortex was dissected from 19-20 WKSG human samples, male and female cases, and dissociated according to the manufacturer's protocol into a single cell suspension (MACs neural dissociation kit, Miltenyi Biotec). Cortical neurons were plated onto poly-ornithine and laminin treated coverslips at 5 3 10 4 cells/well in 24-well plates and maintained in DMEM/Neurobasal, N2, B27, glucose, NaHCO3, HEPES (4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid) with fibroblast growth factor 2 (FGF-2; 20 ng/mL; Invitrogen) and EGF (FGF-2; 20 ng/mL; Invitrogen) treatment for the first 24 h only. Neurons were transfected with mCherry vector together with each experimental condition at a 1:6 plasmid ratio as described above ( Figure S2 ). Cultured medium was changed every other day. Neurons were fixed after 5 days in vitro (DIV 5) with 4% PFA in PBS for 15 min. at room temperature. Cells were blocked in 10% NGS in PBS with 0.3% Triton X-100 for 1 h at room temperature followed by immunostaining. Images were captured using a digital camera under a Zeiss Axio Observer fluorescent microscope. 30-50 neurons were analyzed from three separate coverslips for each experimental condition. Neurites that had lengths at least twice the diameter of the cell body were measured. Neurite lengths from the soma were traced and measured using ImageJ software in a blinded manner, and data were analyzed using Igor Pro Software. Statistical significance was assessed with Student's two-tailed t test.
Ferret brain magnetic resonance imaging
Three P30 ferret brains (expressing SCN3A-WT, SCN3A-F1759Y, and mCherry) were post-fixed in 4% paraformaldehyde in PBS and submerged into perfluorocarbon oil (Fomblin, Fisher Scientific) at 4 C for 3 days. The brains were scanned using a Bruker BioSpec 70/30 7T MRI scanner (Small Animal Imaging Laboratory) at BCH. This is a high-resolution (sub-millimeter) MRI scanner designed specifically for imaging small animals, and has a 30 cm bore and 450 mT/m gradient. Ferret MRI scans are isotropic 63 mm voxels across the entire brain. Cortical gray matter and white matter were visualized using the FreeSurfer and OsiriX software.
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